Shelia Jin

5.3k total citations · 3 hit papers
28 papers, 3.9k citations indexed

About

Shelia Jin is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Geriatrics and Gerontology. According to data from OpenAlex, Shelia Jin has authored 28 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 6 papers in Economics and Econometrics and 5 papers in Geriatrics and Gerontology. Recurrent topics in Shelia Jin's work include Dementia and Cognitive Impairment Research (15 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Frailty in Older Adults (5 papers). Shelia Jin is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Frailty in Older Adults (5 papers). Shelia Jin collaborates with scholars based in United States. Shelia Jin's co-authors include Ronald G. Thomas, Leon J. Thal, Michael Grundman, Mary Sano, Eric Pfeiffer, Rachelle S. Doody, Christopher H. van Dyck, Steven H. Ferris, Douglas Galasko and David Bennett and has published in prestigious journals such as New England Journal of Medicine, Neurology and American Journal of Epidemiology.

In The Last Decade

Shelia Jin

28 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

2005 1.3k citations Ronald Petersen, Ronald G. Thomas et al. New England Journal of Medicine profile →
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

2003 744 citations Paul Aisen, Kimberly Schafer et al. PubMed profile →
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

2000 736 citations Ruth A. Mulnard, Carl W. Cotman et al. PubMed profile →

Peers

Shelia Jin

PHYSI

PMH

PHARM

NEURO

EDM

Ara S. Khachaturian United States

Kimberly Schafer United States

Cristiano Capurso Italy

Lon S. Schneider United States

María M. Corrada United States

P. Kragh‐Sørensen Denmark

Vincenza Frisardi Italy

Neal R. Cutler United States

Marzia Baldereschi Italy

Jae H. Kang United States

Ara S. Khachaturian United States

Shelia Jin

1.8k ×1.2

PHYSI

1.4k ×1.1

PMH

863 ×1.0

PHARM

627 ×1.0

NEURO

161 ×0.3

EDM

Citations per year, relative to Shelia Jin Shelia Jin (= 1×) peers Ara S. Khachaturian

Countries citing papers authored by Shelia Jin

Since Specialization

Citations

This map shows the geographic impact of Shelia Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelia Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelia Jin more than expected).

Fields of papers citing papers by Shelia Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelia Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelia Jin. The network helps show where Shelia Jin may publish in the future.

Co-authorship network of co-authors of Shelia Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Shelia Jin. A scholar is included among the top collaborators of Shelia Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelia Jin. Shelia Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shadyab, Aladdin H., Diane M. Jacobs, David P. Salmon, et al.. (2025). Effects of exercise versus usual care on older adults with amnestic mild cognitive impairment: EXERT versus ADNI. Alzheimer s & Dementia. 21(4). e70118–e70118. 1 indexed citations

Baker, Laura D., Carl W. Cotman, Ronald J. Thomas, et al.. (2022). Topline Results of EXERT: Can Exercise Slow Cognitive Decline in MCI?. Alzheimer s & Dementia. 18(S11). 4 indexed citations

Schneider, Lon S., Yuqi Qiu, Ronald G. Thomas, et al.. (2021). Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study. Alzheimer s Research & Therapy. 13(1). 201–201. 4 indexed citations

Aisen, Paul, Lon S. Schneider, Mary Sano, et al.. (2013). High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease. 5 indexed citations

Corey‐Bloom, Jody, Tanya Wolfson, Anthony Gamst, et al.. (2012). Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. Canadian Medical Association Journal. 184(10). 1143–1150. 152 indexed citations

Rafii, Michael S., Sally Walsh, John T. Little, et al.. (2011). A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 76(16). 1389–1394. 175 indexed citations

Tractenberg, Rochelle E., et al.. (2010). Sample Size Requirements for Training to a κ Agreement Criterion on Clinical Dementia Ratings. Alzheimer Disease & Associated Disorders. 24(3). 264–268. 18 indexed citations

Chambers, Christina, Diana L. Johnson, Luther K. Robinson, et al.. (2010). Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis & Rheumatism. 62(5). 1494–1503. 140 indexed citations

Jack, Clifford R., Ronald C. Petersen, Michael Grundman, et al.. (2007). Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiology of Aging. 29(9). 1285–1295. 99 indexed citations

10.

Salmon, David P., Jeffrey L. Cummings, Shelia Jin, et al.. (2006). ADCS Prevention Instrument Project: Development of a Brief Verbal Memory Test for Primary Prevention Clinical Trials. Alzheimer Disease & Associated Disorders. 20(Supplement 3). S139–S146. 8 indexed citations

11.

Sano, Mary, Susan Egelko, Shelia Jin, et al.. (2006). Spanish Instrument Protocol: New Treatment Efficacy Instruments for Spanish-speaking Patients in Alzheimer Disease Clinical Trials. Alzheimer Disease & Associated Disorders. 20(4). 232–241. 14 indexed citations

12.

Galasko, Douglas, Frederick A. Schmitt, Ronald G. Thomas, et al.. (2005). Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. Journal of the International Neuropsychological Society. 11(4). 446–453. 129 indexed citations

13.

Petersen, Ronald, Ronald G. Thomas, Michael Grundman, et al.. (2005). Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. New England Journal of Medicine. 352(23). 2379–2388. 1330 indexed citations breakdown →

14.

Weiner, Myron, Rochelle E. Tractenberg, Shelia Jin, et al.. (2002). Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications. Journal of Psychiatric Research. 36(1). 19–25. 26 indexed citations

15.

Mulnard, Ruth A., Carl W. Cotman, Claudia H. Kawas, et al.. (2000). Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial. Obstetrical & Gynecological Survey. 439–440. 38 indexed citations

16.

Galasko, Douglas, Frederick A. Schmitt, Shelia Jin, et al.. (2000). Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease. Neurobiology of Aging. 21. 168–168. 33 indexed citations

17.

Tractenberg, Rochelle E., Shelia Jin, Marian B. Patterson, et al.. (2000). Qualifying Change: A Method for Defining Clinically Meaningful Outcomes of Change Score Computation. Journal of the American Geriatrics Society. 48(11). 1478–1482. 11 indexed citations

18.

Weiner, Myron, Elisabeth Koss, Marian B. Patterson, et al.. (1998). A comparison of the Cohen-Mansfield agitation inventory with the cerad behavioral rating scale for dementia in community-dwelling persons with Alzheimers disease. Journal of Psychiatric Research. 32(6). 347–351. 19 indexed citations

19.

Sano, Mary, Joan Mackell, Marcel O. Pontón, et al.. (1997). The Spanish Instrument Protocol. Alzheimer Disease & Associated Disorders. 11. 57–64. 19 indexed citations

20.

Sano, Mary, Joan Mackell, Marcel O. Pontón, et al.. (1997). The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study.. PubMed. 11 Suppl 2. S57–64. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact